SOPHIA GENETICS SA
SOPH · NASDAQ
Updated at 2026-10-13 14:43:15
- Today's High
- $7.33
- Today’s Low
- $7.11
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $7.44
- Previous Close
- $7.22
- Volume
- 478.88K
- Market Cap
- $614.62M
- P/E Ratio
- --
- EPS
- $-1.15
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- HEALTH INFORMATION SERVICES
- Headquarters
- LA PIECE 12, ROLLE, SWITZERLAND, 1180
- Country
- CH
- Listing Date
- 2021-07-23
- Fiscal Year End
- December
- Shares Outstanding
- 83.9M
- CIK
- 0001840706
- Website
- www.sophiagenetics.com
Sophia Genetics SA (SOPH) stands at the forefront of data-driven medicine, delivering advanced genomic and clinical data analytics that significantly enhance patient outcomes. Utilizing cutting-edge machine learning technologies, the company provides an integrated platform designed to help healthcare providers navigate complex genomic data, facilitating personalized treatment strategies in oncology, rare diseases, and hereditary conditions. With a robust global footprint and strategic partnerships with leading healthcare organizations, Sophia Genetics is well-positioned to transform the precision medicine landscape and solidify its role as a key player in the genomics industry.
Financial Metrics
Revenue
2026-06-30
$23.31M
2026-03-31
$21.68M
2025-12-31
$21.7M
2025-09-30
$19.46M
Operating Expenses
2026-06-30
$35.11M
2026-03-31
$32.03M
2025-12-31
$32.74M
2025-09-30
$30.76M
Net Income
2026-06-30
-$22.35M
2026-03-31
-$19.32M
2025-12-31
-$19.17M
2025-09-30
-$20.02M
Net Profit Margin
2026-06-30
-95.9%
2026-03-31
-89.09%
2025-12-31
-88.35%
2025-09-30
-102.87%
Earnings Per Share
2026-06-30
$-0.26
2026-03-31
$-0.19
2025-12-31
$-0.17
2025-09-30
$-0.20
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$17.75M
2026-03-31
-$14.65M
2025-12-31
-$15.46M
2025-09-30
-$15.91M
Effective Tax Rate
2026-06-30
-0.35%
2026-03-31
-1.32%
2025-12-31
2.01%
2025-09-30
-3.31%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $23.31M | $21.68M | $21.7M | $19.46M |
| Operating Expenses | $35.11M | $32.03M | $32.74M | $30.76M |
| Net Income | -$22.35M | -$19.32M | -$19.17M | -$20.02M |
| Net Profit Margin | -95.9% | -89.09% | -88.35% | -102.87% |
| Earnings Per Share | $-0.26 | $-0.19 | $-0.17 | $-0.20 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$17.75M | -$14.65M | -$15.46M | -$15.91M |
| Effective Tax Rate | -0.35% | -1.32% | 2.01% | -3.31% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.